Patent · US Active

Methods of activating RET receptor tyrosine kinase using neurotrophic factors

US7655463B2 · kind B2 · utility

11Cited by
36References
16Claims
0Family size

Assignees

Inventors

Key dates

Filing dateFeb 12, 2008
Grant dateFeb 2, 2010
Priority date
Expiry dateFeb 12, 2028

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to neublastin neurotrophic factor polypeptides, nucleic acids encoding neublastin polypeptides, and antibodies that bind specifically to neublastin polypeptides, as well as methods of making and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.